Rumberger John M, Wu Tong, Hering Michelle A, Marshall Stephen
Hexos, Inc., Woodinville, Washington 98072, USA.
J Biol Chem. 2003 Aug 1;278(31):28547-52. doi: 10.1074/jbc.M302793200. Epub 2003 May 20.
Glucose uptake into adipose and liver cells is known to up-regulate mRNA levels for various lipogenic enzymes such as fatty acid synthase (FAS) and acetyl-CoA carboxylase (ACC). To determine whether the hexosamine biosynthesis pathway (HBP) mediates glucose regulation of mRNA expression, we treated primary cultured adipocytes for 18 h with insulin (25 ng/ml) and either glucose (20 mm) or glucosamine (2 mm). A ribonuclease protection assay was used to quantitate mRNA levels for FAS, ACC, and glycerol-3-P dehydrogenase (GPDH). Treatment with insulin and various concentrations of d-glucose increased mRNA levels for FAS (280%), ACC (93%), and GPDH (633%) in a dose-dependent manner (ED50 8-16 mm). Mannose similarly elevated mRNA levels, but galactose and fructose were only partially effective. l-glucose had no effect. Omission of glutamine from the culture medium markedly diminished the stimulatory effect of glucose on mRNA expression. Since glutamine is a crucial amide donor in hexosamine biosynthesis, we interpret these data to mean that glucose flux through the HBP is linked to regulation of lipogenesis through control of gene expression. Further evidence for hexosamine regulation was obtained using glucosamine, which is readily transported into adipocytes where it directly enters the HBP. Glucosamine was 15-30 times more potent than glucose in elevating FAS, ACC, and GPDH mRNA levels (ED50 approximately 0.5 mm). In summary: 1) GPDH, FAS, and ACC mRNA levels are upregulated by glucose; 2) glucose-induced up-regulation requires glutamine; and 3) mRNA levels for lipogenic enzymes are up-regulated by glucosamine. Hyperglycemia is the hallmark of diabetes mellitus and leads to insulin resistance, impaired glucose metabolism, and dyslipidemia. We postulate that disease pathophysiology may have a common underlying factor, excessive glucose flux through the HBP.
已知脂肪细胞和肝细胞摄取葡萄糖会上调多种生脂酶的mRNA水平,如脂肪酸合酶(FAS)和乙酰辅酶A羧化酶(ACC)。为了确定己糖胺生物合成途径(HBP)是否介导葡萄糖对mRNA表达的调控,我们用胰岛素(25 ng/ml)以及葡萄糖(20 mM)或氨基葡萄糖(2 mM)处理原代培养的脂肪细胞18小时。采用核糖核酸酶保护试验来定量FAS、ACC和甘油-3-磷酸脱氢酶(GPDH)的mRNA水平。用胰岛素和不同浓度的d-葡萄糖处理后,FAS(280%)、ACC(93%)和GPDH(633%)的mRNA水平呈剂量依赖性升高(半数有效浓度8 - 16 mM)。甘露糖同样能提高mRNA水平,但半乳糖和果糖的作用仅部分有效。l-葡萄糖则无作用。从培养基中去除谷氨酰胺会显著减弱葡萄糖对mRNA表达的刺激作用。由于谷氨酰胺是己糖胺生物合成中关键的酰胺供体,我们认为这些数据意味着葡萄糖通过HBP的通量与通过基因表达控制脂肪生成的调控相关。使用氨基葡萄糖获得了更多关于己糖胺调控的证据,氨基葡萄糖易于转运到脂肪细胞中并直接进入HBP。在提高FAS、ACC和GPDH mRNA水平方面,氨基葡萄糖的效力比葡萄糖强15 - 30倍(半数有效浓度约为0.5 mM)。总之:1)葡萄糖上调GPDH、FAS和ACC的mRNA水平;2)葡萄糖诱导的上调需要谷氨酰胺;3)生脂酶的mRNA水平被氨基葡萄糖上调。高血糖是糖尿病的标志,会导致胰岛素抵抗、葡萄糖代谢受损和血脂异常。我们推测疾病的病理生理学可能有一个共同的潜在因素,即葡萄糖通过HBP的通量过多。